The Directorate General of Drug Administration (DGDA) has invited Ganashashthya Kendra (GK) for discussion. The discussion is scheduled to be held on Sunday.
Covid-19 Rapid Dot Blot Kit Project Coordinator Dr. Muhib Ullah Khondoker confirmed the information.
He said, we requested for an appointment schedule and they provided us the schedule. They have called us for a meeting on post test result situation of antibody test kits.
On the other hand, in a separate press release quoting Dr. Zafrullah Chowdhury it was said, Director General of DGDA has called the GK officials to get informed about updated antibody kit data and information. If DGDA offers permission for the kit then we will produce 5000 antibody kits within 15 days. The GK researchers are updating the antibody kits. We hope that DGDA will be satisfied and permit us.